undamentalytics Newsletter
Sign in

Century Therapeutics, Inc. balance sheet

At the end of fiscal 2025, Century Therapeutics, Inc. had total assets of $224m, total liabilities of $64.8m and shareholders' equity of $159m. It held $61.9m in cash against $0 of debt: net cash of $61.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Cash and equivalents84475862
Total current assets320177194121
Total assets487361353224
Accounts payable5335
Deferred revenue (current)74109—
Total current liabilities301813020
Long-term debt4———
Total debt10—00
Total liabilities18417619265
Shareholders' equity303185161159
Net debt (negative = net cash)−74−47−58−62
Shares outstanding—60m86m88m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: IPSC vs XNCRIPSC vs KYMRIPSC vs SPRY

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Century Therapeutics, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Century Therapeutics, Inc.